MARY BETH YENTZ: Open Payments
NPI 1073097655 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 30 payments from 9 companies in 2025. Trend: 2023 $496 · 2024 $408 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $155 |
| Axsome Therapeutics, Inc. | 2 | $143 |
| Otsuka America Pharmaceutical, Inc. | 12 | $142 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Corium, LLC | 3 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Auvelity, REXULTI, LYBALVI, COBENFY, ARISTADA, CAPLYTA, Azstarys, VIVITROL.
Industry payments across MA — which companies pay providers there.
